Your browser doesn't support javascript.
loading
Pharmacodynamic Response to Anti-thyroid Drugs in Graves' Hyperthyroidism.
Abbara, Ali; Clarke, Sophie A; Brewster, Rosalind; Simonnard, Alexia; Eng, Pei Chia; Phylactou, Maria; Papadopoulou, Deborah; Izzi-Engbeaya, Chioma; Sam, Amir H; Wernig, Florian; Jonauskyte, Eliza; Comninos, Alexander N; Meeran, Karim; Kelsey, Tom W; Dhillo, Waljit S.
Afiliação
  • Abbara A; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Clarke SA; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Brewster R; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Simonnard A; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Eng PC; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Phylactou M; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Papadopoulou D; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Izzi-Engbeaya C; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Sam AH; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Wernig F; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Jonauskyte E; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Comninos AN; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Meeran K; Section of Endocrinology and Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Hammersmith Hospital, Imperial College London, London, United Kingdom.
  • Kelsey TW; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.
  • Dhillo WS; Department of Endocrinology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Front Endocrinol (Lausanne) ; 11: 286, 2020.
Article em En | MEDLINE | ID: mdl-32477269
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male Idioma: En Ano de publicação: 2020 Tipo de documento: Article